Sun Pharmaceuticals Industries Ltd Share Price Sun Pharma.Inds.

401.65

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

401.40

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

402.00

Open ()
Open Interest
(Contracts)
VWAP ()
Day's Vol
(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 27-Jul-2019 - -
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2019 Outcome of the Board Meeting of the Company held today (As Per BSE Announcement Dated On 13/08/2019)
Board Meeting - 10-May-2019 - -
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, May 28, 2019, inter alia, to transact following business: (i) To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2019. (ii) To consider recommendation of dividend for the year ended March 31 , 2019 subject to the approval of the shareholders at the ensuing Annual General Meeting. Further, kindly note that pursuant to the Companys Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on April 4, 2019, and shall end after 48 hours of the declaration of financial results of the Company on May 28, 2019. This is for your information and record. Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended payment of dividend of Rs. 2.75/- (Rupees Two and parse seventy five Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2019, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or about last week of August, 2019 or first week of September, 2019. Outcome of the Board Meeting of the Company held today Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended payment of dividend of Rs. 2.75/- (Rupees Two and parse seventy five Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2019, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or about last week of August, 2019 or first week of September, 2019. Change in Designation of Mr. Sudhir V. Valia : Please note that Mr. Sudhir Valia stepped down from the position of Whole-time Director of the Company to Non-Executive Director of the Company, with effect from 29th May, 2019, therefore he shall continue as a Non-Executive and Non-Independent Director of the Company. (As Per BSE Announcement Dated On 28/05/2019)
Board Meeting - 25-Jan-2019 - -
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, February 12, 2019, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31,2018. In view of the above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Friday, February 01,2019 to Thursday, February 14, 2019 (both days inclusive). This is for your information and record. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Tuesday, February 12,201 9, have duly approved and took on record the limited reviewed Unaudited standalone Financial Results and Unaudited Consolidated Financial Results for the quarter and nine months ended December 31, 2018, which are enclosed herewith alongwith the Limited Review Report of the Statutory Auditors of the Company on Standalone and Consolidated Unaudited Financial Results. The meeting of the Board of Directors of the Company commenced at 12:10 p.m. and concluded at 04:05 p.m. (As Per BSE Announcement Dated on 12/02/2019)
Board Meeting - 22-Oct-2018 - -
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, November 13, 2018, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2018. In view of the above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Wednesday, October 31, 2018 to Thursday, November 15, 2018 (both days inclusive). This is for your information and record. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Tuesday, November 13, 2018, have approved and took on record the limited reviewed Unaudited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter and half year ended September 30, 2018, which are enclosed herewith alongwith the Limited Review Report of the Statutory Auditors of the Company on Standalone and Consolidated Unaudited Financial Results. (As Per BSE Announcement Dated on 13.11.2018)